Evidence map›Paper›PMID 40839798›Full record

ArticleThe journal of physical chemistry. A2025

IR Action Spectroscopy of Mass- and Mobility-Selected α-Synuclein Segments: Structure Identification in Early-Stage Oligomers via the Amide A Region.

Agathe Depraz Depland, Olivier Verhoev, Steven Daly, Anouk M Rijs

Abstract read
In one paragraph

Article in The journal of physical chemistry. A, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Agathe Depraz DeplandDivision of Bioanalytical Chemistry, Department of Chemistry and Pharmaceutical Sciences, Amsterdam Institute of Molecular and Life Sciences, Vrije Universiteit Amsterdam, De Boelelaan 1105, 1081 HV Amsterdam, The Netherlands.
Olivier VerhoevDivision of Bioanalytical Chemistry, Department of Chemistry and Pharmaceutical Sciences, Amsterdam Institute of Molecular and Life Sciences, Vrije Universiteit Amsterdam, De Boelelaan 1105, 1081 HV Amsterdam, The Netherlands.
Steven DalyMS-Vision, Televisieweg 40, 1322 AM Almere, Netherlands.ORCID 0000-0002-3268-8247
Anouk M RijsDivision of Bioanalytical Chemistry, Department of Chemistry and Pharmaceutical Sciences, Amsterdam Institute of Molecular and Life Sciences, Vrije Universiteit Amsterdam, De Boelelaan 1105, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0002-7446-9907

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is associated with protein misfolding and aggregation of α-Synuclein (α-Syn), a process central to its pathology. Understanding the early structural transitions of α-Syn is crucial, yet detailed insights into oligomeric intermediates remain elusive. Using the novel Photo-Synapt spectrometer, which integrates ion mobility mass spectrometry (IM-MS) with infrared multiple-photon dissociation (IRMPD) spectroscopy, we investigated the secondary structures of key α-Syn peptide segments, namely, WT-PD1 (NACore) and WT-PD2 (pre-NAC). This unique approach enabled conformationally selective analysis, allowing peptide monomers and oligomers to be separated based on both mass and mobility. Despite sequence similarities, these peptides exhibit distinct monomeric structures and aggregation behavior, leading to different oligomer assemblies with unique IR signatures. By analyzing the amide A region (3100-3500 cm

Indexed as

alpha-SynucleinAmidesAmino Acid SequenceHumansIon Mobility SpectrometryMass SpectrometryProtein Structure, SecondarySpectrophotometry, Infraredalpha-SynucleinAmides

Identifiers

PMID40839798
PMCPMC12415830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.